{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:55:22Z","timestamp":1792814122767,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Our purpose was to compare postoperative infectious endophthalmitis rates before and after the introduction of antibiotic prophylaxis via intracameral with cefuroxime (ATB-P IC) in a high-volume cataract surgery service. Retrospective cohort study considering patients who underwent cataract surgery at Ophthal Hospital Especializado, S\u00e3o Paulo, Brazil, from January\/2011 to December\/2019. Patients operated from 2013 to 2019 comprised the ATB-P IC group while those operated from 2011 to 2013 formed the control group without the ATB-P IC protocol. A total of 23,184 cataract surgeries were included, with 6,207 in the Control Group and 16,977 in the ATB-P Group. A significantly higher rate of endophthalmitis was observed in the control group (0.0967%) when compared to the ATB-P group (0.0177%) (<jats:italic>p<\/jats:italic>\u2009=\u20090.014). Surgeries performed with ATB-P showed 80% less chance of reported endophthalmitis (OR\u2009=\u20090.20; 95% CI 0.05\u20130.72; <jats:italic>p<\/jats:italic>\u2009=\u20090.014) than those without ATB-P. Of the six cases confirmed by culture in the control group, all tested positive for <jats:italic>Pseudomonas aeroginosa<\/jats:italic> and the only case confirmed by culture in the ATB-P group was positive for <jats:italic>Staphylococcus epidermidis.<\/jats:italic> Our findings strongly support the use of intracameral antibiotic prophylaxis with cefuroxime to reduce postoperative infectious endophthalmitis rates, and we recommend its incorporation into cataract surgery protocols.<\/jats:p>","DOI":"10.1038\/s41598-023-45398-4","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T14:03:05Z","timestamp":1697896985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The impact of antibiotic prophylaxis with intracameral cefuroxime on postoperative infectious endophthalmitis rates in a high-volume cataract surgery center"],"prefix":"10.1038","volume":"13","author":[{"given":"Luciane Nunes","family":"de Sousa Casavechia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Carlos","family":"Meireles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro","family":"Schapira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Antonio Brant","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7525-1838","authenticated-orcid":false,"given":"Arthur Gustavo","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,21]]},"reference":[{"key":"45398_CR1","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","volume":"113","author":"Endophthalmitis Vitrectomy Study Group","year":"1995","unstructured":"Endophthalmitis Vitrectomy Study Group. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch. Ophthalmol. 113, 1479\u20131496 (1995).","journal-title":"Arch. Ophthalmol."},{"key":"45398_CR2","first-page":"387","volume-title":"CBO","author":"F Or\u00e9fice","year":"2013","unstructured":"Or\u00e9fice, F. & Freitas Neto, C. A. Uve\u00edtes 3 ed. In CBO 3rd edn (ed. Alves, M. R.) 387\u2013394 (Cultura M\u00e9dica, Rio de Janeiro, 2013).","edition":"3"},{"key":"45398_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0039-6257(98)00036-8","volume":"43","author":"MS Kresloff","year":"1998","unstructured":"Kresloff, M. S., Castellarin, A. A. & Zarbin, M. A. Endophthalmitis. Surv Ophthalmol. 43, 193\u2013224 (1998).","journal-title":"Surv Ophthalmol."},{"key":"45398_CR4","doi-asserted-by":"publisher","first-page":"e71731","DOI":"10.1371\/journal.pone.0071731","volume":"8","author":"H Cao","year":"2013","unstructured":"Cao, H., Zhang, L., Li, L. & Lo, S. Risk factors for acute endophthalmitis following cataract surgery: A systematic review and meta-analysis. PLoS One. 8, e71731 (2013).","journal-title":"PLoS One."},{"key":"45398_CR5","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ophtha.2011.11.023","volume":"119","author":"L Keay","year":"2012","unstructured":"Keay, L., Gower, E. W., Cassard, S. D., Tielsch, J. M. & Schein, O. D. Postcataract surgery endophthalmitis in the United States: Analysis of the complete 2003 to 2004 Medicare database of cataract surgeries. Ophthalmology 119, 914\u2013922 (2012).","journal-title":"Ophthalmology"},{"key":"45398_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1590\/S0104-42302002000400013","volume":"48","author":"ASS Levin","year":"2002","unstructured":"Levin, A. S. S. Quais os princ\u00edpios gerais da profilaxia antibi\u00f3ti-ca antes de interven\u00e7\u00e3o cir\u00fargica?. Rev. Assoc. Med. Bras. 48, 282 (2002).","journal-title":"Rev. Assoc. Med. Bras."},{"key":"45398_CR7","first-page":"95","volume":"9","author":"K Vaziri","year":"2015","unstructured":"Vaziri, K., Schwartz, S. G., Kishor, K. & Flynn, H. W. Jr. Endophthalmitis: State of the art. Clin. Ophthalmol. 9, 95\u2013108 (2015).","journal-title":"Clin. Ophthalmol."},{"key":"45398_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/OPTH.S6461","volume":"4","author":"M Kernt","year":"2010","unstructured":"Kernt, M. & Kampik, A. Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives. Clin. Ophthalmol. 4, 121\u2013135 (2010).","journal-title":"Clin. Ophthalmol."},{"key":"45398_CR9","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","volume":"98","author":"MG Speaker","year":"1991","unstructured":"Speaker, M. G. & Menikoff, J. A. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology 98, 1769\u20131775 (1991).","journal-title":"Ophthalmology"},{"key":"45398_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0161-6420(01)00899-5","volume":"109","author":"TA Ciulla","year":"2002","unstructured":"Ciulla, T. A., Starr, M. B. & Masket, S. Bacterial endophthalmitis prophylaxis for cataract surgery: An evidence-based update. Ophthalmology 109, 13\u201324 (2002).","journal-title":"Ophthalmology"},{"key":"45398_CR11","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.4103\/ijo.IJO_961_17","volume":"65","author":"A Haripriya","year":"2017","unstructured":"Haripriya, A. Antibiotic prophylaxis in cataract surgery\u2014an evidence-based approach. Indian J. Ophthalmol. 65, 1390\u20131395 (2017).","journal-title":"Indian J. Ophthalmol."},{"key":"45398_CR12","unstructured":"Barry P, Cordov\u00e9s L, Gardner S. ESCRS Guidelines for Prevention and Treatment of Endophthalmitis Following Cataract Surgery: Data, Dilemmas and Conclusions. The European Society for Cataract & Refractive Surgeons. https:\/\/www.escrs.org\/media\/uljgvpn1\/english_2018_updated.pdf (2013)."},{"key":"45398_CR13","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jcrs.2007.02.032","volume":"33","author":"Endophthalmitis Study Group","year":"2007","unstructured":"Endophthalmitis Study Group. Prophylaxis of postoperative endophthalmitis following cataract surgery: Results of the ESCRS multicenter study and identification of risk factors. J. Cataract Refract. Surg. 33, 978\u2013988 (2007).","journal-title":"J. Cataract Refract. Surg."},{"key":"45398_CR14","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/AAC.13.4.657","volume":"13","author":"HC Neu","year":"1978","unstructured":"Neu, H. C. & Fu, K. P. Cefuroxime, a beta-lactamase-resistant cephalosporin with a broad spectrum of gram-positive and -negative activity. Antimicrob. Agents Chemother. 13, 657\u2013664 (1978).","journal-title":"Antimicrob. Agents Chemother."},{"key":"45398_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jcrs.2006.02.021","volume":"32","author":"P Barry","year":"2006","unstructured":"Barry, P. et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery: Preliminary report of principal results from a European multicenter study. J. Cataract Refract. Surg. 32, 407\u2013410 (2006).","journal-title":"J. Cataract Refract. Surg."},{"key":"45398_CR16","doi-asserted-by":"publisher","first-page":"17416","DOI":"10.1038\/s41598-022-21423-w","volume":"12","author":"A Kato","year":"2022","unstructured":"Kato, A. et al. Prophylactic antibiotics for postcataract surgery endophthalmitis: A systematic review and network meta-analysis of 6.8 million eyes. Sci. Rep. 12, 17416 (2022).","journal-title":"Sci. Rep."},{"key":"45398_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/1469-0691.12118","volume":"19","author":"ML Durand","year":"2013","unstructured":"Durand, M. L. Endophthalmitis. Clin. Microbiol. Infect. 19, 227\u2013234 (2013).","journal-title":"Clin. Microbiol. Infect."},{"key":"45398_CR18","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1136\/bjophthalmol-2017-311051","volume":"102","author":"RC Bowen","year":"2018","unstructured":"Bowen, R. C. et al. Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: A meta-analysis. Br. J. Ophthalmol. 102, 1268\u20131276 (2018).","journal-title":"Br. J. Ophthalmol."},{"key":"45398_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/aos.12684","volume":"93","author":"L Kessel","year":"2015","unstructured":"Kessel, L. et al. Antibiotic prevention of postcataract endophthalmitis: A systematic review and meta-analysis. Acta Ophthalmol. 93, 303\u2013317 (2015).","journal-title":"Acta Ophthalmol."},{"key":"45398_CR20","first-page":"1","volume":"3","author":"MR Alves","year":"2017","unstructured":"Alves, M. R., Victor, G., Carricondo, P. C. & Nose, R. M. Moxifloxacino, cefuroxima e vancomicina intracameral: Espectro de atividade, preparo, seguran\u00e7a e efic\u00e1cia. Rev. Dig. Oftalmol. 3, 1\u20137 (2017).","journal-title":"Rev. Dig. Oftalmol."},{"key":"45398_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5935\/0004-2749.20180022","volume":"81","author":"NP Lucena","year":"2018","unstructured":"Lucena, N. P. et al. Intracameral moxifloxacin after cataract surgery: A prospective study. Arq. Bras. Oftalmol. 81, 92\u201394 (2018).","journal-title":"Arq. Bras. Oftalmol."},{"key":"45398_CR22","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.jcrs.2019.04.018","volume":"45","author":"A Haripriya","year":"2019","unstructured":"Haripriya, A., Chang, D. F. & Ravindran, R. D. Endophthalmitis reduction with intracameral moxifloxacin in eyes with and without surgical complications: Results from 2 million consecutive cataract surgeries. J. Cataract Refract. Surg. 45, 1226\u20131233 (2019).","journal-title":"J. Cataract Refract. Surg."},{"key":"45398_CR23","unstructured":"Food and Drug Administration FDA. Vancomycin Injection. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/050671s024lbl.pdf (2017)."},{"key":"45398_CR24","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","volume":"4","author":"WC Reygaert","year":"2018","unstructured":"Reygaert, W. C. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 4, 482\u2013501 (2018).","journal-title":"AIMS Microbiol."},{"key":"45398_CR25","unstructured":"Laboratoires Th\u00e9a, Clermont-Ferrand, France. Aprokam\u00ae https:\/\/www.medicines.org.uk\/emc\/medicine\/27397#gref (2020)."},{"key":"45398_CR26","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1016\/j.jcrs.2019.06.009","volume":"45","author":"SA Arshinoff","year":"2019","unstructured":"Arshinoff, S. A., Felfeli, T. & Modabber, M. Aqueous level abatement profiles of intracameral antibiotics: A comparative mathematical model of moxifloxacin, cefuroxime, and vancomycin with determination of relative efficacies. J. Cataract Refract. Surg. 45, 1568\u20131574 (2019).","journal-title":"J. Cataract Refract. Surg."},{"key":"45398_CR27","first-page":"18","volume":"32","author":"MR Pires","year":"2012","unstructured":"Pires, M. R. et al. Avalia\u00e7\u00e3o do uso de cefazolina como profilaxia antibi\u00f3tica em procedimentos cir\u00fargicos. Rev. HCPA 32, 18\u201323 (2012).","journal-title":"Rev. HCPA"},{"key":"45398_CR28","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1742-7843.2011.00729.x","volume":"109","author":"A Vaajanen","year":"2011","unstructured":"Vaajanen, A. & Vapaatalo, H. Local ocular renin-angiotensin system - a target for glaucoma therapy?. Basic Clin. Pharmacol. Toxicol. 109, 217\u2013224 (2011).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"45398_CR29","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/00498254.2019.1624872","volume":"50","author":"RK Jairam","year":"2020","unstructured":"Jairam, R. K. et al. Uptake and pharmacokinetics of cefuroxime in rabbits after intravitreal, intracameral, and topical dosing: Relevance to human ocular injection of cefuroxime. Xenobiotica 50, 339\u2013345 (2020).","journal-title":"Xenobiotica"},{"key":"45398_CR30","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.oret.2020.09.010","volume":"5","author":"SJR de Geus","year":"2021","unstructured":"de Geus, S. J. R., Hopman, J., Br\u00fcggemann, R. J., Klevering, B. J. & Crama, N. Acute endophthalmitis after cataract surgery: Clinical characteristics and the role of intracameral antibiotic prophylaxis. Ophthalmol. Retina 5, 503\u2013510 (2021).","journal-title":"Ophthalmol. Retina"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45398-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45398-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45398-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T22:18:06Z","timestamp":1700259486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-45398-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,21]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["45398"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-45398-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,21]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18031"}}